Wealthcare Advisory Partners’s Guardant Health GH Stock Holding History

Wealthcare Advisory Partners’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$813K	Sell	5,421 -56	-1%	-$6.09K	0.02%	572
2026 Q1	$506K	Sell	5,477 -2,658	-33%	-$267K	0.01%	696
2025 Q4	$831K	Sell	8,135 -122	-1%	-$10.9K	0.02%	563
2025 Q3	$516K	Buy	8,257 +25	+0.3%	+$1.36K	0.01%	670
2025 Q2	$428K	Buy	8,232 +7	+0.1%	+$313	0.01%	682
2025 Q1	$350K	Sell	8,225 -30	-0.4%	-$1.29K	0.01%	686
2024 Q4	$252K	Buy	+8,255	New	+$232K	0.01%	770
2024 Q3	–	Sell	-8,635	Closed	-$249K	–	887
2024 Q2	$249K	Buy	+8,635	New	+$201K	0.01%	731
2024 Q1	–	Sell	-8,596	Closed	-$233K	–	818
2023 Q4	$233K	Buy	8,596 +1,308	+18%	+$34.3K	0.01%	679
2023 Q3	$216K	Sell	7,288 -10	-0.1%	-$352	0.01%	637
2023 Q2	$261K	Buy	+7,298	New	+$210K	0.01%	608
2023 Q1	–	Sell	-7,951	Closed	-$216K	–	712
2022 Q4	$216K	Sell	7,951 -181	-2%	-$8.28K	0.01%	637
2022 Q3	$438K	Buy	8,132 +220	+3%	+$11.3K	0.03%	393
2022 Q2	$319K	Buy	7,912 +2,128	+37%	+$105K	0.02%	412
2022 Q1	$383K	Sell	5,784 -108	-2%	-$7.39K	0.02%	361
2021 Q4	$589K	Buy	5,892 +774	+15%	+$80.1K	0.04%	289
2021 Q3	$640K	Sell	5,118 -69	-1%	-$8.2K	0.04%	272
2021 Q2	$644K	Buy	5,187 +696	+15%	+$93.6K	0.04%	263
2021 Q1	$686K	Buy	4,491 +2,764	+160%	+$418K	0.05%	236
2020 Q4	$223K	Buy	+1,727	New	+$199K	0.02%	375
2020 Q2	–	Sell	-564	Closed	-$39K	–	740
2020 Q1	$39K	Buy	+564	New	+$43.3K	0.01%	560

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Wealthcare Advisory Partners's GH Position: Q2 2026 in Review

Wealthcare Advisory Partners reduced its Guardant Health (GH) stake by 1% in Q2 2026, selling an estimated $6.09K and leaving 5,421 shares worth $813K. The position accounts for 0.02% of the portfolio, ranked #572.

Wealthcare Advisory Partners first reported a position in GH in Q1 2020 and has held it in 21 quarters since. The position peaked at $831K in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Wealthcare Advisory Partners held 5,421 shares of Guardant Health worth $813K as of Q2 2026.
Wealthcare Advisory Partners sold 56 Guardant Health shares in Q2 2026, an estimated $6.09K.
Guardant Health made up 0.02% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #572 holding.
Wealthcare Advisory Partners first reported a position in Guardant Health in Q1 2020 and has held it in 21 quarters since.
Wealthcare Advisory Partners's Guardant Health position peaked at $831K in Q4 2025.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.